Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The FMC Corporation (NYSE: FMC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a global agricultural sciences company focused on crop protection, biologicals, crop nutrition, and digital and precision agriculture, FMC uses its SEC reports to detail its financial condition, restructuring activities, capital structure and governance.
Investors can review current reports on Form 8-K, where FMC discloses material events such as quarterly earnings releases, leadership changes, restructuring initiatives and credit agreement amendments. For example, the company has filed 8-Ks describing quarterly financial results, the comprehensive Project Foundation cost optimization plan and Manufacturing Restructuring Program, and an amendment to its Fifth Amended and Restated Credit Agreement that adjusts leverage and interest coverage covenants and places conditions on dividends and indebtedness.
Through its periodic annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via EDGAR and summarized on this page), FMC provides more detailed information on revenue by region, cost structure, research and development spending on new herbicide, insecticide and fungicide active ingredients, and risks related to competition, regulation and restructuring. These filings also describe the company’s geographic footprint, including its headquarters in Philadelphia, Pennsylvania, and its operations across North America, Latin America, Asia and EMEA.
The filings page also highlights governance and board-related disclosures, such as 8-K reports on director resignations or executive departures, and may include proxy materials that discuss executive compensation and board composition. For those monitoring capital structure and liquidity, filings related to credit facilities, covenant changes and potential asset sales—such as the planned divestiture of the India commercial business—are particularly relevant.
Stock Titan enhances these documents with AI-powered summaries that explain key points in plain language, helping users interpret complex sections of lengthy 10-Ks, 10-Qs and 8-Ks. Real-time updates from EDGAR ensure that new filings, including any Form 4 insider transaction reports or additional restructuring disclosures, appear promptly so investors can track how FMC’s financial and strategic decisions evolve over time.
FMC Corporation (FMC) – Form 4 insider activity filed for Director Eduardo E. Cordeiro.
- Transaction date: 17 Jul 2025
- Securities acquired: 237 common shares at $0 through dividend-equivalent rights associated with previously vested RSUs (non-open-market, code A).
- Post-transaction holding: 31,321 common shares held directly.
- No derivative securities reported; no dispositions, sales, or option exercises disclosed.
The filing reflects a routine, low-value increase in ownership—approximately 0.0002 % of FMC’s 126 m shares outstanding—therefore unlikely to be market-moving. However, continued accumulation, even via dividend equivalents, may signal long-term alignment between the director and shareholders.